11q deletion in neuroblastoma: a review of biological and clinical implications

Abstract

Deletion of the long arm of chromosome 11 (11q deletion) is one of the most frequent events that occur during the development of aggressive neuroblastoma. Clinically, 11q deletion is associated with higher disease stage and decreased survival probability. During the last 25 years, extensive efforts have been invested to identify the precise frequency of 11q aberrations in neuroblastoma, the recurrently involved genes, and to understand the molecular mechanisms of 11q deletion, but definitive answers are still unclear. In this review, it is our intent to compile and review the evidence acquired to date on 11q deletion in neuroblastoma.

DOI: 10.1186/s12943-017-0686-8

3 Figures and Tables

Cite this paper

@inproceedings{Mlakar201711qDI, title={11q deletion in neuroblastoma: a review of biological and clinical implications}, author={Vid Mlakar and Simona Jurkovi{\vc} Mlakar and Gonzalo L{\'o}pez and John M. Maris and Marc Ansari and Fabienne Gumy-Pause}, booktitle={Molecular Cancer}, year={2017} }